OKUR
OnKure Therapeutics
OKUR
OKUR
61 hedge funds and large institutions have $45.4M invested in OnKure Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
10% less funds holding
Funds holding: 68 → 61 (-7)
35% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 20
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
Holders
61
Holding in Top 10
2
Calls
$358K
Puts
$7K
Top Buyers
| 1 | +$2.68M | |
| 2 | +$1.43M | |
| 3 | +$671K | |
| 4 |
AC
Aldebaran Capital
Carmel,
Indiana
|
+$658K |
| 5 |
Renaissance Technologies
New York
|
+$320K |
Top Sellers
| 1 | -$674K | |
| 2 | -$553K | |
| 3 | -$254K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$191K |
| 5 |
VPC
Vestal Point Capital
New York
|
-$174K |